Imiquimod 5% Cream as an Adjunct to Mohs Micrographic Surgery in Basal Cell Carcinoma: A Mixed Methods Systematic Review
Imiquimod shows promise as an adjunct to MMS in specific scenarios, but standardized protocols, cost-effectiveness analysis, and long-term studies are required to validate its efficacy and clinical utility.
Authors
- Marra Aghajani (ORCID: https://orcid.org/0000-0002-8088-4509)
- Gilberto Moreno Bonilla (ORCID: https://orcid.org/0000-0003-4227-8169)
- Alicia Savage
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
Publication Details
- Journal
- Dermatologic Surgery
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1097/dss.0000000000004672
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00